Evaluation of the immature platelet fraction contribute to the differential diagnosis of hereditary, immune and other acquired thrombocytopenias
Abstract The differential diagnosis of immune (ITP) and hereditary macrothrombocytopenia (HM) is key to patient management. The immature platelet fraction (IPF) represents the subset of circulating platelets with higher RNA content, and has been shown to distinguish hypo- from hyperproliferative thr...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6646c7dc9c244b0d87f194744b27fe23 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6646c7dc9c244b0d87f194744b27fe23 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6646c7dc9c244b0d87f194744b27fe232021-12-02T12:30:16ZEvaluation of the immature platelet fraction contribute to the differential diagnosis of hereditary, immune and other acquired thrombocytopenias10.1038/s41598-017-03668-y2045-2322https://doaj.org/article/6646c7dc9c244b0d87f194744b27fe232017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03668-yhttps://doaj.org/toc/2045-2322Abstract The differential diagnosis of immune (ITP) and hereditary macrothrombocytopenia (HM) is key to patient management. The immature platelet fraction (IPF) represents the subset of circulating platelets with higher RNA content, and has been shown to distinguish hypo- from hyperproliferative thrombocytopenias. Here we evaluated the diagnostic accuracy of IPF in the differential diagnosis between HM and other thrombocytopenias in a population of patients with post-chemotherapy thrombocytopenia (n = 56), bone marrow failure (n = 22), ITP (n = 105) and HM (n = 27). TPO levels were also measured in HM and ITP matched for platelet counts. Platelet counts were similar in all patient groups. Higher IPF values were observed in both ITP (12.3%; 2.4–65.6%) and HM (29.8%; 4.6–65.9%) compared to hypoproliferative thrombocytopenias. IPF values were also higher in HM compared to ITP, yielding a diagnostic accuracy of 0.80 (95%CI 0.70–0.90; P < 0.0001) to distinguish these two conditions. Intra- and inter-assays reproducibility of IPF in HM patients revealed that this is a stable parameter. In conclusion, IPF is increased in HM compared to both ITP and other thrombocytopenias and contributes to the differentiation between ITP and HM. Further studies are warranted to understand the biological rationale of these findings and to its incorporation in diagnostic algorithms of HM.F. L. B. FerreiraM. P. ColellaS. S. MedinaC. Costa-LimaM. M. L. FiusaL. N. G. CostaF. A. OrsiJ. M. Annichino-BizzacchiK. Y. FertrinM. F. P. GilbertiM. C. OzeloE. V. De PaulaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-8 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q F. L. B. Ferreira M. P. Colella S. S. Medina C. Costa-Lima M. M. L. Fiusa L. N. G. Costa F. A. Orsi J. M. Annichino-Bizzacchi K. Y. Fertrin M. F. P. Gilberti M. C. Ozelo E. V. De Paula Evaluation of the immature platelet fraction contribute to the differential diagnosis of hereditary, immune and other acquired thrombocytopenias |
description |
Abstract The differential diagnosis of immune (ITP) and hereditary macrothrombocytopenia (HM) is key to patient management. The immature platelet fraction (IPF) represents the subset of circulating platelets with higher RNA content, and has been shown to distinguish hypo- from hyperproliferative thrombocytopenias. Here we evaluated the diagnostic accuracy of IPF in the differential diagnosis between HM and other thrombocytopenias in a population of patients with post-chemotherapy thrombocytopenia (n = 56), bone marrow failure (n = 22), ITP (n = 105) and HM (n = 27). TPO levels were also measured in HM and ITP matched for platelet counts. Platelet counts were similar in all patient groups. Higher IPF values were observed in both ITP (12.3%; 2.4–65.6%) and HM (29.8%; 4.6–65.9%) compared to hypoproliferative thrombocytopenias. IPF values were also higher in HM compared to ITP, yielding a diagnostic accuracy of 0.80 (95%CI 0.70–0.90; P < 0.0001) to distinguish these two conditions. Intra- and inter-assays reproducibility of IPF in HM patients revealed that this is a stable parameter. In conclusion, IPF is increased in HM compared to both ITP and other thrombocytopenias and contributes to the differentiation between ITP and HM. Further studies are warranted to understand the biological rationale of these findings and to its incorporation in diagnostic algorithms of HM. |
format |
article |
author |
F. L. B. Ferreira M. P. Colella S. S. Medina C. Costa-Lima M. M. L. Fiusa L. N. G. Costa F. A. Orsi J. M. Annichino-Bizzacchi K. Y. Fertrin M. F. P. Gilberti M. C. Ozelo E. V. De Paula |
author_facet |
F. L. B. Ferreira M. P. Colella S. S. Medina C. Costa-Lima M. M. L. Fiusa L. N. G. Costa F. A. Orsi J. M. Annichino-Bizzacchi K. Y. Fertrin M. F. P. Gilberti M. C. Ozelo E. V. De Paula |
author_sort |
F. L. B. Ferreira |
title |
Evaluation of the immature platelet fraction contribute to the differential diagnosis of hereditary, immune and other acquired thrombocytopenias |
title_short |
Evaluation of the immature platelet fraction contribute to the differential diagnosis of hereditary, immune and other acquired thrombocytopenias |
title_full |
Evaluation of the immature platelet fraction contribute to the differential diagnosis of hereditary, immune and other acquired thrombocytopenias |
title_fullStr |
Evaluation of the immature platelet fraction contribute to the differential diagnosis of hereditary, immune and other acquired thrombocytopenias |
title_full_unstemmed |
Evaluation of the immature platelet fraction contribute to the differential diagnosis of hereditary, immune and other acquired thrombocytopenias |
title_sort |
evaluation of the immature platelet fraction contribute to the differential diagnosis of hereditary, immune and other acquired thrombocytopenias |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/6646c7dc9c244b0d87f194744b27fe23 |
work_keys_str_mv |
AT flbferreira evaluationoftheimmatureplateletfractioncontributetothedifferentialdiagnosisofhereditaryimmuneandotheracquiredthrombocytopenias AT mpcolella evaluationoftheimmatureplateletfractioncontributetothedifferentialdiagnosisofhereditaryimmuneandotheracquiredthrombocytopenias AT ssmedina evaluationoftheimmatureplateletfractioncontributetothedifferentialdiagnosisofhereditaryimmuneandotheracquiredthrombocytopenias AT ccostalima evaluationoftheimmatureplateletfractioncontributetothedifferentialdiagnosisofhereditaryimmuneandotheracquiredthrombocytopenias AT mmlfiusa evaluationoftheimmatureplateletfractioncontributetothedifferentialdiagnosisofhereditaryimmuneandotheracquiredthrombocytopenias AT lngcosta evaluationoftheimmatureplateletfractioncontributetothedifferentialdiagnosisofhereditaryimmuneandotheracquiredthrombocytopenias AT faorsi evaluationoftheimmatureplateletfractioncontributetothedifferentialdiagnosisofhereditaryimmuneandotheracquiredthrombocytopenias AT jmannichinobizzacchi evaluationoftheimmatureplateletfractioncontributetothedifferentialdiagnosisofhereditaryimmuneandotheracquiredthrombocytopenias AT kyfertrin evaluationoftheimmatureplateletfractioncontributetothedifferentialdiagnosisofhereditaryimmuneandotheracquiredthrombocytopenias AT mfpgilberti evaluationoftheimmatureplateletfractioncontributetothedifferentialdiagnosisofhereditaryimmuneandotheracquiredthrombocytopenias AT mcozelo evaluationoftheimmatureplateletfractioncontributetothedifferentialdiagnosisofhereditaryimmuneandotheracquiredthrombocytopenias AT evdepaula evaluationoftheimmatureplateletfractioncontributetothedifferentialdiagnosisofhereditaryimmuneandotheracquiredthrombocytopenias |
_version_ |
1718394401666891776 |